Nectar Lifesciences Limited
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (4)
Compared with Healthcare companies in India.
P/E ratio
29.9Investors pay ₹29.9 for every ₹1 of Nectar Lifesciences Limited's yearly profit, lower than 64% of Healthcare companies in India.
P/B ratio
0.35The share price is 0.35 times Nectar Lifesciences Limited's book value per share, lower than almost all Healthcare companies in India.
Market cap
₹203 CrThe total market value of all of Nectar Lifesciences Limited's shares at today's price (share price × number of shares), smaller than 91% of Healthcare companies in India. PosiCap size class: Micro Cap.
Dividend yield
NoneNectar Lifesciences Limited does not currently pay a dividend.
Questions
What is Nectar Lifesciences Limited's P/E ratio?
Investors pay ₹29.9 for every ₹1 of Nectar Lifesciences Limited's yearly profit, lower than 64% of Healthcare companies in India.
Does Nectar Lifesciences Limited pay a dividend?
No. Nectar Lifesciences Limited does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.